JetBlue Airways Corporation - Common Stock (JBLU)

Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.

FAA considering reducing flights at Newark Airport due to disruptions caused by equipment and staff shortages.

The weekend saw a flurry of business news, including criticism of Tesla's robotaxi economics, insider stock sales by Tesla's leadership, Ford's 16% sales growth, and JetBlue's potential partnership talks with United Airlines.

JetBlue (JBLU) is discussing a partnership with United (UAL). This could improve connectivity and frequent flier miles

JetBlue (JBLU) shares slip after mixed Q1 2025 results, with adjusted loss of $0.59 per share & $2.14B revenue, down 3.1% YoY. Capacity down 4.3%, loyalty segment strong. Q2 guidance predicts decline in ASM & RASM, growth in CASM ex-fuel & fuel price. Company evaluating ways to boost profitability & preserve cash amidst macro uncertainty.

American also filed a lawsuit against JetBlue over the winding down of the Northeast Alliance (NEA).

US jobs report for March was better-than-expected, renewing focus on some sector-specific ETFs. Healthcare, transportation, and food retail are timely opportunities.

Why JPMorgan analyst Jamie Baker lowers estimates for U.S. airlines in Q2.

JetBlue Airways stock has plunged 35% year to date. A Death Cross formation cements the stock's bearish trend.

A 10% decline in Canadian travel may result in 2 million fewer visits and $2.1 billion in lost spending in U.S. spending.